More articles from Commentary

You have access
Perspectives on the PQRI Extractables and Leachables “Safety Thresholds and Best Practices” Recommendations for Inhalation Drug Products
Daniel L. Norwood, Lee M. Nagao and Cheryl L. M. Stults

PDA Journal of Pharmaceutical Science and Technology September 2013, 67 (5) 413-429; DOI: https://doi.org/10.5731/pdajpst.2013.00934
You have access
Can Quality Solve the Equation? ⇓ Pricing + ⇑ Health Authority Expectations + ⇑ Supply Chain Complexity + ⇑ Counterfeiting = Quality Drugs to Patients + an Engaged Workforce
Jennifer Magnani and Anders Vinther

PDA Journal of Pharmaceutical Science and Technology November 2012, 66 (6) 518-525; DOI: https://doi.org/10.5731/pdajpst.2012.00893
You have access
The Reliability-Quality Relationship for Quality Systems and Quality Risk Management
H. Gregg Claycamp, Faiad Rahaman and Jason M. Urban

PDA Journal of Pharmaceutical Science and Technology November 2012, 66 (6) 512-517; DOI: https://doi.org/10.5731/pdajpst.2012.00888
You have access
Considerations on Auditing and GxP Requirements along the Product Lifecycle
Stephan Rönninger, Siegfried Schmitt, Vijaya Rangavajhula, Emily Hough and Jim Lyda

PDA Journal of Pharmaceutical Science and Technology September 2012, 66 (5) 396-402; DOI: https://doi.org/10.5731/pdajpst.2012.00881
You have access
Reliable Drug Quality: An Unresolved Problem
Janet Woodcock

PDA Journal of Pharmaceutical Science and Technology May 2012, 66 (3) 270-272; DOI: https://doi.org/10.5731/pdajpst.2012.00868
You have access
A General Strategy for the Chemical Aspects of the Safety Assessment of Extractables and Leachables in Pharmaceutical Drug Products: The Chemical Assessment Triad
Dennis Jenke

PDA Journal of Pharmaceutical Science and Technology March 2012, 66 (2) 168-183; DOI: https://doi.org/10.5731/pdajpst.2012.00855
You have access
Probability Concepts in Quality Risk Management
H. Gregg Claycamp

PDA Journal of Pharmaceutical Science and Technology January 2012, 66 (1) 78-89; DOI: https://doi.org/10.5731/pdajpst.2012.00801
You have access
Essential Aspects in Assessing the Safety Impact of Interactions between a Drug Product and Its Associated Manufacturing System
Dennis Jenke

PDA Journal of Pharmaceutical Science and Technology January 2012, 66 (1) 63-77; DOI: https://doi.org/10.5731/pdajpst.2012.00742
You have access
Proposal on How To Conduct a Biopharmaceutical Process Failure Mode and Effect Analysis (FMEA) as a Risk Assessment Tool
Hartmut F. Zimmermann and Norbert Hentschel

PDA Journal of Pharmaceutical Science and Technology September 2011, 65 (5) 506-512; DOI: https://doi.org/10.5731/pdajpst.2011.00784
You have access
Reducing Hospital-Acquired Infection by Quantitative Risk Modeling of Intravenous Bag Preparation
Edward C. Tidswell, Jim Rockwell and Marc-Oliver Wright

PDA Journal of Pharmaceutical Science and Technology March 2010, 64 (2) 82-91;

Main menu

User menu

Search

More articles from Commentary

Pages

Readers

Author/Reviewer Information

Parenteral Drug Association, Inc.